Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹109 Cr₹-357 Cr₹2,621 Cr₹1,270 Cr₹2,804 Cr

What is the latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹109 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹109 Cr
Mar2024₹-357 Cr
Mar2023₹2,621 Cr
Mar2022₹1,270 Cr
Mar2021₹2,804 Cr

How is Total Non-Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹109 Cr
Positive
Mar2024 ₹-357 Cr
Negative
Mar2023 ₹2,621 Cr
106.48
Mar2022 ₹1,270 Cr
-54.72
Mar2021 ₹2,804 Cr -

Compare Total Non-Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,120.1 Cr -1.2% -1.5% 11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,271.0 Cr -0.5% -0.3% 18.9% Stock Analytics
DIVIS LABORATORIES ₹226,843.0 Cr 3.1% 18.9% 33.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,000.0 Cr -1.5% -1.6% 35.6% Stock Analytics
CIPLA ₹118,072.0 Cr -0.9% 1.6% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,073.0 Cr 2% -3.8% -0.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.2%

-1.5%

11.6%

SENSEX

-0.8%

0.5%

-3.8%


You may also like the below Video Courses